📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Teladoc ripen for activist intervention - Jefferies

Published 05/31/2024, 11:15 AM
Updated 05/31/2024, 11:22 AM
© Reuters.  Teladoc (TDOC)
TDOC
-
(Updated - May 31, 2024 11:18 AM EDT)

Can Teladoc (NYSE:TDOC) be heading for an intervention by an activist investor? Analysts at Jefferies believe so.

There's no denying the telemedicine company can use a change of course - its shares are down over 96% since the pandemic highs, and have lost nearly 50% through the first half of 2024 alone.

Analysts at Jefferies, in their most recent note, reiterated their doubts in the company's current strategy.

They note that "BetterHelp growth has been disappointing," and while "Integrated Care has pillared the growth & margin expansion," they still have questions over "the LT demand for chronic and primary care services."

As such, the analysts voice their concerns that the current management appears to "believe the company has the right assets/strategy, and is just in need of operational leadership," whereas they see the need for an "overall strategic review," in order to restructure productive assets and cut unnecessary costs.

They conclude: "With leadership in transition, & the average Board tenure at 6.2 yrs, with 6 of 9 members pre-dating the Livongo trans, shares seem ripe for structural change. An activist could influence the CEO decision, claim some Board seats, & be instrumental in reshaping the strategy."

Jefferies reiterated a Hold rating on the shares, but lowered the Price Target to $10 from $14.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.